Real‐World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims Database

Documenti analoghi

• The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia–Pacific Region: A Cross‐Sectional Real‐World Study
  di: Keira Herr, et al.
  Pubblicazione: (2025)
• Increased Cerebrospinal Fluid Lactate Levels in Schizophrenia and Major Depressive Disorder: NCNP Biobank Study in Japan
  di: Hideo Hagihara, et al.
  Pubblicazione: (2026)
• Vortioxetine Can Be Used Safely to Treat Depression After Implantable Cardioverter Defibrillator Implantation for Congenital Long QT Syndrome: A Case Report
  di: Makio Yamauchi, et al.
  Pubblicazione: (2025)
• A web‐based survey on the occurrence of emotional blunting in patients with major depressive disorder in Japan: Patient perceptions and attitudes
  di: Toshiaki Kikuchi, et al.
  Pubblicazione: (2024)
• Treatment Persistence of Paliperidone Palmitate 3‐Month in Patients With Schizophrenia: A Japan Medical Data Center Claims Database Analysis
  di: Akihide Wakamatsu, et al.
  Pubblicazione: (2025)